Drug Shortage Report for VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP
Report ID | 127028 |
Drug Identification Number | 02230191 |
Brand name | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP |
Common or Proper name | Vancomycin Hydrochloride for Injection, USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | VANCOMYCIN |
Strength(s) | 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 x 10mL vial |
ATC code | J01XA |
ATC description | OTHER ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-12-28 |
Actual start date | |
Estimated end date | |
Actual end date | 2021-02-03 |
Shortage status | Resolved |
Updated date | 2021-02-04 |
Company comments | |
Health Canada comments | |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.